Duane Nash's most recent trade in Immunic Inc was a trade of 20,000 Common Stock done at an average price of $0.8 . Disclosure was reported to the exchange on June 13, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Immunic Inc | Duane D. Nash | Director, Executive Chairman | Purchase of securities on an exchange or from another person at price $ 0.83 per share. | 13 Jun 2025 | 20,000 | 36,032 (0%) | 0% | 0.8 | 16,694 | Common Stock |
| Immunic Inc | Duane D. Nash | Director, Executive Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2025 | 560,000 | 560,000 | - | - | Stock Option | |
| Immunic Inc | D. Nash Duane | Director, Executive Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Dec 2024 | 300,000 | 300,000 | - | - | Stock Option | |
| Immunic Inc | Duane D. Nash | Director, Executive Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2024 | 379,959 | 379,959 | - | - | Stock Option | |
| Immunic Inc | Duane D. Nash | Director, Executive Chairman | Sale or transfer of securities back to the company at price $ 0.00 per share. | 04 Mar 2024 | 120,000 | 0 | - | - | Stock Option | |
| Immunic Inc | Duane D. Nash | Director, Executive Chairman | Sale or transfer of securities back to the company at price $ 0.00 per share. | 04 Mar 2024 | 90,000 | 0 | - | - | Stock Option | |
| Immunic Inc | Duane D. Nash | Director, Executive Chairman | Sale or transfer of securities back to the company at price $ 0.00 per share. | 04 Mar 2024 | 75,000 | 0 | - | - | Stock Option | |
| Immunic Inc | Duane D. Nash | Director, Executive Chairman | Sale or transfer of securities back to the company at price $ 0.00 per share. | 04 Mar 2024 | 30,000 | 0 | - | - | Stock Option | |
| Immunic Inc | Duane D. Nash | Director, Executive Chairman | Sale or transfer of securities back to the company at price $ 0.00 per share. | 04 Mar 2024 | 19,973 | 0 | - | - | Stock Option | |
| Immunic Inc | Duane D. Nash | Director, Executive Chairman | Sale or transfer of securities back to the company at price $ 0.00 per share. | 04 Mar 2024 | 15,000 | 0 | - | - | Stock Option | |
| Immunic Inc | Duane D. Nash | Director, Executive Chairman | Sale or transfer of securities back to the company at price $ 0.00 per share. | 04 Mar 2024 | 10,000 | 0 | - | - | Stock Option | |
| Immunic Inc | Duane D. Nash | Director, Executive Chairman | Sale or transfer of securities back to the company at price $ 0.00 per share. | 04 Mar 2024 | 10,000 | 0 | - | - | Stock Option | |
| Immunic Inc | Duane D. Nash | Director, Executive Chairman | Sale or transfer of securities back to the company at price $ 0.00 per share. | 04 Mar 2024 | 9,986 | 0 | - | - | Stock Option | |
| Immunic Inc | Duane D. Nash | Director, Executive Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2024 | 300,000 | 300,000 | - | - | Stock Option | |
| Immunic Inc | Duane D. Nash | Director, Executive Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2023 | 132,000 | 132,000 | - | - | Stock Option | |
| Immunic Inc | Duane D. Nash | Director, Executive Chairman | Purchase of securities on an exchange or from another person at price $ 5.03 per share. | 12 May 2022 | 10,000 | 22,032 (0%) | 0% | 5.0 | 50,300 | Common Stock |
| Immunic Inc | Duane D. Nash | Director, Executive Chairman | Gift of securities by or to the insider at price $ 0.00 per share. | 12 May 2022 | 6,000 | 16,032 (0%) | 0% | 0 | Common Stock | |
| Immunic Inc | Duane D. Nash | Director, Executive Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2022 | 75,000 | 75,000 | - | - | Stock Option | |
| Immunic Inc | Duane D. Nash | Director, Executive Chairman | Purchase of securities on an exchange or from another person at price $ 9.80 per share. | 10 Aug 2021 | 1,000 | 15,032 (0%) | 0% | 9.8 | 9,800 | Common Stock |
| Immunic Inc | Duane D. Nash | Director, Executive Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2021 | 10,000 | 10,000 | - | - | Stock Option | |
| Immunic Inc | Duane D. Nash | Director, Executive Chairman | Purchase of securities on an exchange or from another person at price $ 12.75 per share. | 12 May 2021 | 4,000 | 14,032 (0%) | 0% | 12.8 | 51,000 | Common Stock |
| Immunic Inc | Duane D. Nash | Director, Executive Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Apr 2021 | 90,000 | 90,000 | - | - | Stock Option | |
| Immunic Inc | Duane D. Nash | Director, Executive Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Oct 2020 | 120,000 | 120,000 | - | - | Stock Option | |
| Immunic Inc | Duane D. Nash | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jul 2020 | 45,000 | 45,000 | - | - | Stock Option |